| id |
oapen-20.500.12657-39724
|
| record_format |
dspace
|
| spelling |
oapen-20.500.12657-397242023-07-14T12:11:49Z Kostensensible Leitlinien Marckmann, Georg cost sensitivity assessment of benefit scarcity of capital evidence based medicine prioritization MBN bic Book Industry Communication::M Medicine::MB Medicine: general issues::MBN Public health & preventive medicine Medical innovations and demographic change will further exacerbate the financial situation in the German healthcare system in the coming years. The evidence-based allocation of the limited funds available will therefore become increasingly important. From an ethical perspective, allocation decisions should be based on clearly defined procedures and criteria. So far, however, there are no concrete approaches on how this explicit performance control can be implemented in practice. The book provides an overview of the results of the interdisciplinary research association ""Allocation"", which for the first time examined the possibilities and limits of explicit performance management in two selected practical areas (interventional cardiology and intensive care medicine). Two exemplary cost-sensitive guidelines have been developed that enable an evidence-based balance between efficiency and justice. The legal requirements for such an explicit benefit management in statutory health insurance were examined in detail. Healthcare professionals and patients were asked for their assessments of the strengths and weaknesses of the cost-sensitive guidelines. 2020-06-18T10:03:50Z 2020-06-18T10:03:50Z 2015 book http://library.oapen.org/handle/20.500.12657/39724 ger application/pdf Attribution-NonCommercial-NoDerivatives 4.0 International kostensensible-leitlinien.pdf MWV Medizinisch Wissenschaftliche Verlagsgesellschaft 10.32745/9783954664580-2 10.32745/9783954664580-2 9401348f-9594-4fba-a966-b475c0b6e6f0 Knowledge Unlatched Knowledge Unlatched (KU) 209 Berlin 105934 open access
|
| institution |
OAPEN
|
| collection |
DSpace
|
| language |
German
|
| description |
Medical innovations and demographic change will further exacerbate the financial situation in the German healthcare system in the coming years. The evidence-based allocation of the limited funds available will therefore become increasingly important. From an ethical perspective, allocation decisions should be based on clearly defined procedures and criteria. So far, however, there are no concrete approaches on how this explicit performance control can be implemented in practice.
The book provides an overview of the results of the interdisciplinary research association ""Allocation"", which for the first time examined the possibilities and limits of explicit performance management in two selected practical areas (interventional cardiology and intensive care medicine). Two exemplary cost-sensitive guidelines have been developed that enable an evidence-based balance between efficiency and justice. The legal requirements for such an explicit benefit management in statutory health insurance were examined in detail. Healthcare professionals and patients were asked for their assessments of the strengths and weaknesses of the cost-sensitive guidelines.
|
| title |
kostensensible-leitlinien.pdf
|
| spellingShingle |
kostensensible-leitlinien.pdf
|
| title_short |
kostensensible-leitlinien.pdf
|
| title_full |
kostensensible-leitlinien.pdf
|
| title_fullStr |
kostensensible-leitlinien.pdf
|
| title_full_unstemmed |
kostensensible-leitlinien.pdf
|
| title_sort |
kostensensible-leitlinien.pdf
|
| publisher |
MWV Medizinisch Wissenschaftliche Verlagsgesellschaft
|
| publishDate |
2020
|
| _version_ |
1799945193665855488
|
